These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30610541)

  • 21. [Drug-drug interactions with risk of QT-prolongation. A epidemiological study in Belgian community pharmacies].
    Vandael E; De WuLf I; Foulon V
    J Pharm Belg; 2016 Dec; (4):14-23. PubMed ID: 30281244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Translation Process of Pharmaceutical Care Network Europe v9.00 to Bahasa Indonesia: An Instrument to Detect Drug-Related Problem.
    Satria MA; Andrajati R; Supardi S
    Malays J Med Sci; 2022 Jun; 29(3):133-144. PubMed ID: 35846501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of a comprehensive classification tool for treatment-related problems.
    AbuRuz SM; Bulatova NR; Yousef AM
    Pharm World Sci; 2006 Aug; 28(4):222-32. PubMed ID: 17066238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cross-sectional study of the Belgian community pharmacist's satisfaction with the implementation of the electronic prescription.
    Van Laere S; Cornu P; Buyl R
    Int J Med Inform; 2020 Mar; 135():104069. PubMed ID: 31915117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identify and categorize drug-related problems in hospitalized surgical patients in China.
    Qu C; Meng L; Wang N; Chen Y; Yang X; Wang J; Sun S; Qiu F
    Int J Clin Pharm; 2019 Feb; 41(1):13-17. PubMed ID: 30610549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of medication therapy management on pharmacotherapy safety in an intensive care unit.
    Martins RR; Silva LT; Lopes FM
    Int J Clin Pharm; 2019 Feb; 41(1):179-188. PubMed ID: 30552623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of an instrument for the documentation of clinical pharmacists' interventions.
    Allenet B; Bedouch P; Rose FX; Escofier L; Roubille R; Charpiat B; Juste M; Conort O
    Pharm World Sci; 2006 Aug; 28(4):181-8. PubMed ID: 17066245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in China.
    Zhu Y; Liu C; Zhang Y; Shi Q; Kong Y; Wang M; Xia X; Zhang F
    Int J Clin Pharm; 2019 Dec; 41(6):1570-1577. PubMed ID: 31654364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability.
    Hohmann C; Eickhoff C; Klotz JM; Schulz M; Radziwill R
    J Clin Pharm Ther; 2012 Jun; 37(3):276-81. PubMed ID: 21790687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do pharmacists counsel customers about the effects of sedating antihistamines on driving skills? A survey of community pharmacies in Saudi Arabia.
    Khojah HM
    J Int Med Res; 2019 May; 47(5):2018-2025. PubMed ID: 30885078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introducing clinical pharmacy services to cardiovascular clinics at a university hospital in Northern Cyprus.
    Al-Baghdadi H; Koca Al-Baghdadi Ç; Abdi A; Gültekin O; Meštrović A; Demirdamar R; Özcem B; Başgut B
    Int J Clin Pharm; 2017 Dec; 39(6):1185-1193. PubMed ID: 28975485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Belgian community pharmacists' pharmacovigilance perspective and practice.
    De Meestere D; Saevels J
    Res Social Adm Pharm; 2019 Dec; 15(12):1446-1452. PubMed ID: 30733138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Documentation of pharmaceutical care: development of an intervention oriented classification system.
    Maes KA; Bruch S; Hersberger KE; Lampert ML
    Int J Clin Pharm; 2017 Apr; 39(2):354-363. PubMed ID: 28251442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The status of the performance of medication reviews in German community pharmacies and assessment of the practical performance.
    Greißing C; Kössler K; Freyer J; Hüter L; Buchal P; Schiek S; Bertsche T
    Int J Clin Pharm; 2016 Dec; 38(6):1425-1435. PubMed ID: 27783313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems.
    Williams M; Peterson GM; Tenni PC; Bindoff IK
    Int J Pharm Pract; 2012 Aug; 20(4):238-48. PubMed ID: 22775520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an aggregated system for classifying causes of drug-related problems.
    Basger BJ; Moles RJ; Chen TF
    Ann Pharmacother; 2015 Apr; 49(4):405-18. PubMed ID: 25614526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.